Methods of treating thyroid eye disease

TW202635338APending Publication Date: 2026-09-01HORIZON THERAPEUTICS IRELAND DAC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114104798
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-10-30
Filing Date
2025-02-10
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001073629_001
    Figure TWG2TA001073629_001
  • Figure TWG2TA001073629_002
    Figure TWG2TA001073629_002
  • Figure TWG2TA001073629_003
    Figure TWG2TA001073629_003
Patent Text Reader

Abstract

The present invention relates to methods for treating or reducing the severity of thyroid eye disease. In particular, the present invention provides methods for treating or reducing the severity of thyroid eye disease in patients in need thereof comprising administering an IGF-1R antagonist antibody according to specific dosage regimens. Pharmaceutical compositions comprising the IGF-1R antagonist antibody for use in the methods are also described.
Need to check novelty before this filing date? Find Prior Art